Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Early treatment with high-dose interferon beta-1areverses cognitive and cortical plasticity deficits in multiple sclerosis.
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases.
Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes.
Biomarkers in multiple sclerosis: an update for 2014.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.
Autonomic dysfunction in multiple sclerosis.
The Immune Pathogenesis of Multiple Sclerosis.
Diffusion tensor imaging in pediatric transverse myelitis: A case study.
Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
A novel activity for fungal nitronate monooxygenase: Detoxification of the metabolic inhibitor propionate-3-nitronate.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Spring cleaning: time to rethink imaging research lines in MS?
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Pages
« first
‹ previous
…
315
316
317
318
319
320
321
322
323
…
next ›
last »